Neuropsychopharmacology

FIGURE 3

FROM:

Blockade by the Cannabinoid CB1 Receptor Antagonist, Rimonabant (SR141716), of the Potentiation by Quinelorane of Food-Primed Reinstatement of Food-Seeking Behavior

Christine Duarte, Richard Alonso, Nicole Bichet, Caroline Cohen, Philippe Soubrié and Marie-Hélène Thiébot

BACK TO ARTICLE

Figure 3.

Figure and tables index
Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, please contact help@nature.com or the author

Effect of rimonabant on Fos expression in D3+/+ and D3-/- mice. Animals were given either vehicle (Veh) or rimonabant (SR, 10 mg/kg, i.p.), 2 h before being killed. Data are the number (mean+SEM) of Fos-positive cells counted within the indicated brain region (n=8 in D3+/+ and D3-/- mice for each treatment group). * p<0.05; ** p<0.01 rimonabant vs vehicle, in mice of the same genotype; †† p<0.01 vs rimonabant-treated D3+/+ mice; NS: not significant (Dunn's t-test after ANOVA).

Figure and tables index
BACK TO ARTICLE